Shares of Blue Jet Healthcare Ltd. declined nearly 10% on Tuesday, November 4, after the company reported a weak set of earnings for the September quarter.

Its net profit declined 10.8% to ₹52 crore in the second quarter compared to ₹58.3 crore in the same period last year.

The company's revenue was down 20.6% at ₹165.4 crore from ₹208.2 crore it reported in the September quarter last year.

Its earnings before interest, taxes, depreciation and amortisation (EBITDA) declined 21% to ₹55 crore in the September quarter from ₹69.4 crore last year.

Its margin contracted marginally to 33.1% from 33.3% in the year-ago period.

Blue Jet Healthcare, which listed in 2023, manufactures specialty pharmaceutical and healthcare ingredients used in contrast media, high-intensity sweeteners and regul

See Full Page